NCT01181115 - Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Multiple Sclerosis

Interventions

DRUG

Avonex

Interferon treatment for MS

Trial Locations (10)

Research Site, Baotou

Research Site, Beijing

Research Site, Changchun

Research Site, Chengdu

Research Site, Guangzhou

Research Site, Hangzhou

Research Site, Nanchang

Research Site, Shanghai

Research Site, Taiyuan

Research Site, Xi'an